18 May 2015
AstraZeneca to Invest $285M in New Biologics Facility in Sweden
The new facility in Södertälje will focus on protein therapeutics, create 150-250 jobs, and support clinical trials and commercial production by 2019, enhancing the local life sciences sector.
